HK1158066A1 - A polypeptide for use in treating dengue virus infections - Google Patents

A polypeptide for use in treating dengue virus infections

Info

Publication number
HK1158066A1
HK1158066A1 HK11112416.8A HK11112416A HK1158066A1 HK 1158066 A1 HK1158066 A1 HK 1158066A1 HK 11112416 A HK11112416 A HK 11112416A HK 1158066 A1 HK1158066 A1 HK 1158066A1
Authority
HK
Hong Kong
Prior art keywords
polypeptide
dengue virus
virus infections
treating dengue
treating
Prior art date
Application number
HK11112416.8A
Other languages
English (en)
Chinese (zh)
Inventor
Neil M Bodie
Original Assignee
Trinity Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trinity Therapeutics Inc filed Critical Trinity Therapeutics Inc
Publication of HK1158066A1 publication Critical patent/HK1158066A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HK11112416.8A 2008-07-18 2011-11-17 A polypeptide for use in treating dengue virus infections HK1158066A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8194308P 2008-07-18 2008-07-18
PCT/US2009/050966 WO2010009380A2 (en) 2008-07-18 2009-07-17 Methods for treating immune-mediated dengue fever infections and antibody-dependent enhancement of dengue fever infections, including dengue hemorrhagic fever and dengue shock syndrome

Publications (1)

Publication Number Publication Date
HK1158066A1 true HK1158066A1 (en) 2012-07-13

Family

ID=41551029

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11112416.8A HK1158066A1 (en) 2008-07-18 2011-11-17 A polypeptide for use in treating dengue virus infections

Country Status (14)

Country Link
US (1) US8815813B2 (xx)
EP (1) EP2320924B1 (xx)
JP (1) JP5806112B2 (xx)
CN (1) CN102159231B (xx)
AU (2) AU2009270805B2 (xx)
BR (1) BRPI0915968B1 (xx)
CA (1) CA2731218A1 (xx)
HK (1) HK1158066A1 (xx)
HR (1) HRP20150620T1 (xx)
IL (1) IL210717A (xx)
MX (1) MX2011000647A (xx)
MY (1) MY160699A (xx)
SG (1) SG10201500597YA (xx)
WO (1) WO2010009380A2 (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1950394B (zh) 2004-03-10 2014-04-02 三一治疗公司 在受试者中抑制免疫复合物形成的方法
BRPI0915968B1 (pt) 2008-07-18 2021-11-23 Trinity Therapeutics, inc Uso de polipeptídeo purificado para tratar infecção pelo vírus da dengue
EP3236986A4 (en) * 2014-12-22 2018-10-24 Middle Tennessee State University Methods for treating immune-mediated viral infections
KR102651537B1 (ko) * 2015-05-20 2024-03-25 가고시마 유니버시티 IgG 결합 펩타이드에 의한 항체의 특이적 변형
WO2017189891A1 (en) * 2016-04-27 2017-11-02 Middle Tennessee State University Methods for treating zika viral infections and associated complications
CN115804362A (zh) * 2023-02-08 2023-03-17 中国医学科学院医学生物学研究所 一种IFN-α/βR-/-小鼠抗体依赖性增强感染的注射液及其制备方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5189014A (en) * 1979-12-03 1993-02-23 Cowan Jr Fred M Method of treating cellular Fc receptor mediated hypersensitivity immune disorders
US4383317A (en) * 1980-10-30 1983-05-10 Bei Electronics, Inc. Shaft angle encoder having a circuit for synthesizing a skipped track output signal
IT1190891B (it) 1982-06-24 1988-02-24 Anic Spa Metodo per la sintesi in fase solida di polipeptidi retroinvertiti
US5693758A (en) * 1987-11-19 1997-12-02 501 Research Corporation Limited Immunoglobulin E competitor
US5932483A (en) * 1990-10-16 1999-08-03 Northwestern University Synthetic peptide and its uses
US6407213B1 (en) * 1991-06-14 2002-06-18 Genentech, Inc. Method for making humanized antibodies
US6420127B1 (en) * 1994-11-18 2002-07-16 Washington University Compounds and pharmaceutical compositions for the treatment and prophylaxis of bacterial infections
JP2000505068A (ja) * 1996-03-13 2000-04-25 トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルベニア 補体活性化を阻害する新規ペプチド類
ITMI962628A1 (it) 1996-12-16 1998-06-16 Tecnogen Scpa Composizione farmaceutica
JP2002524504A (ja) * 1998-09-11 2002-08-06 イレクサス・ピーティーワイ・リミテッド Ｆｃ受容体調節剤およびそれの使用
US20030190740A1 (en) 1998-10-13 2003-10-09 The University Of Georgia Research Foundation, Inc Stabilized bioactive peptides and methods of identification, synthesis, and use
JP2002534059A (ja) * 1998-10-13 2002-10-15 ザ ユニバーシティ オブ ジョージア リサーチファウンデーション，インコーポレイティド 安定化された生物活性ペプチドおよび同定、合成および使用方法
US7608681B2 (en) 1999-12-24 2009-10-27 Genentech, Inc. Methods and compositions for prolonging elimination half-times of bioactive compounds
DE50112802D1 (de) 2000-11-08 2007-09-13 Fresenius Medical Care Affina Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
US6916904B2 (en) * 2002-04-24 2005-07-12 Zolaris Biosciences, Llc Inhibition of immune complex formation
NZ536963A (en) 2002-06-07 2008-04-30 Trillium Therapeutics Inc Use of the discovery that Fc gamma receptor IIA transgenic animals are susceptible to autoimmune disease, to suppress aberrant immune activity and to treat or prevent autoimmune disease
AU2002953533A0 (en) 2002-12-24 2003-01-16 Arthron Limited Fc receptor modulating compounds and compositions
CN1950394B (zh) * 2004-03-10 2014-04-02 三一治疗公司 在受试者中抑制免疫复合物形成的方法
DK1789067T3 (da) * 2004-08-12 2012-08-27 Helsinn Healthcare Sa Anvendelse af væksthormonsekretionsfremkaldere til stimulering af mave-tarm-systemets motilitet
EP1940436B1 (en) * 2005-09-06 2013-12-04 Trinity Therapeutics, Inc. Methods for treating immune mediated neurological diseases
ATE499384T1 (de) 2005-12-13 2011-03-15 Suppremol Gmbh Multimere fc-rezeptor-polypeptide
WO2009023777A2 (en) 2007-08-14 2009-02-19 Trinity Therapeutics, Inc. Methods for treating immune thrombocytopenia
BRPI0915968B1 (pt) 2008-07-18 2021-11-23 Trinity Therapeutics, inc Uso de polipeptídeo purificado para tratar infecção pelo vírus da dengue

Also Published As

Publication number Publication date
SG10201500597YA (en) 2015-04-29
US20110218157A1 (en) 2011-09-08
EP2320924A4 (en) 2012-07-25
AU2017200760A1 (en) 2017-03-02
BRPI0915968A2 (pt) 2020-08-18
IL210717A (en) 2017-07-31
AU2009270805A1 (en) 2010-01-21
WO2010009380A9 (en) 2010-04-08
MY160699A (en) 2017-03-15
BRPI0915968B1 (pt) 2021-11-23
AU2009270805B2 (en) 2016-11-03
CN102159231B (zh) 2016-06-15
US8815813B2 (en) 2014-08-26
IL210717A0 (en) 2011-03-31
EP2320924B1 (en) 2015-03-11
MX2011000647A (es) 2011-09-29
EP2320924A1 (en) 2011-05-18
WO2010009380A2 (en) 2010-01-21
CA2731218A1 (en) 2010-01-21
CN102159231A (zh) 2011-08-17
JP5806112B2 (ja) 2015-11-10
HRP20150620T1 (xx) 2015-09-25
JP2011528665A (ja) 2011-11-24

Similar Documents

Publication Publication Date Title
HK1250936A1 (zh) 用於治療病毒感染的化合物和方法
SI2310034T1 (sl) Peptidi za zdravljenje beta-amiloidoz
HRP20150620T1 (xx) Polipeptid za uporabu kod lijeäśenja infekcija denga virusom
ZA201107521B (en) 4 -cyano- 3 -benzoylamino-n-phenyl-benzamides for use in pest control
EP2298801A4 (en) GLYCOSYLATED GLP-1 PEPTIDE
HK1223946A1 (zh) 生物活性肽
ZA201008295B (en) Improvements in feedwells
DK2268666T3 (da) Rekombinant FSH indbefattende alpha-2,3- og alpha-2,6-sialylering
GB0807424D0 (en) Virus
IL217562A0 (en) Treatment with alpha 7-selective ligands
DK2352876T3 (da) Behandlet tekstilmateriale til anvendelse i vandige miljøer
GB0920981D0 (en) Peptides
ZA201100019B (en) Variant hhip1 protein and methods and uses thereof
EP2285827A4 (en) PEPTIDES AND ITS USE
EP2358740A4 (en) CYCLIC PEPTIDES AND USES THEREOF
GB0807870D0 (en) Improvements in actuators
GB0920987D0 (en) Peptides
GB0823560D0 (en) Virus
GB0817978D0 (en) Peptides
GB0823515D0 (en) Improvements in bivvies
GB0816561D0 (en) Peptides and uses thereof
GB0810378D0 (en) Virus
GB0813823D0 (en) Virus
GB0812093D0 (en) Phylloseptin peptides
GB0815673D0 (en) Peptides

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20210714